Industry Insights

India's aesthetic healthcare market shows a pattern similar to what was seen in South Korea in the 2000s, Brazil in the 2010s, and more recently in India's fintech sector: latent demand, a maturing consumer base, and a fragmented supply chain ready for change through investment and technology.

 

The figures are notable: an anticipated valuation of $17 billion by 2030, with a CAGR of 15–18%, and current market penetration at 4%, versus a conservative target of 11%. More importantly, three forces have simultaneously become crucial: consumer affluence, digital infrastructure, and clinical supply. Their convergence leads to category inflection points instead of gradual growth.